APA način citiranja

Fury, M. G., Baxi, S., Shen, R., Kelly, K. W., Lipson, B. L., Carlson, D., . . . Pfister, D. G. (2011). Phase II Study of Saracatinib (AZD0530) for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC).

Čikaški stil citiranja

Fury, Matthew G., Shrujal Baxi, Ronglai Shen, Katherine W. Kelly, Brynna L. Lipson, Diane Carlson, Hilda Stambuk, Sofia Haque, i David G. Pfister. Phase II Study of Saracatinib (AZD0530) for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC). 2011.

MLA način citiranja

Fury, Matthew G., et al. Phase II Study of Saracatinib (AZD0530) for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC). 2011.